Oxygen Makers Rally On High Demand As Covid-19 Infections Surge
Shares of oxygen gas and cylinder makers rallied in an otherwise weak market session on rising demand for oxygen gas as Covid-19 infections continue to rise in the country. The shares of Linde India, which specialises in making gases, rose as much as 10 per cent to hit an all-time high of Rs 2,078.60 on the BSE and Everest Kanto Cylinders, which specialises in making cylinders, was locked in the 20 per cent upper circuit at an all-time high of Rs 92.25. A shortage of oxygen gas, amid high demand due to rising Covid-19 cases, is pushing the share price of these companies higher, analysts said.
Hit by the second Covid wave, India recorded 2,73,810 fresh infections and 1,619 deaths in a new record high in the past 24 hours, taking the caseload to 1.5 crore; 1.78 lakh people have died so far. This is the fifth straight day that over 2 lakh cases were reported.
The demand for medical oxygen has gone through the roof, amid spiralling coronavirus cases in the country. There have been reports of medical oxygen shortages from several states and Union Territories, including Maharashtra and Delhi.
The supply of oxygen meant for industries will now be diverted for medical use in the country as it battles a record surge in the Covid-19 cases in the deadly second wave of the pandemic, said a letter from the government to the chief secretaries of all the states.
The government's move is aimed at plugging the oxygen gap in the country, particularly in the high-burden states - Maharashtra, Madhya Pradesh, Gujarat, Delhi, Uttar Pradesh, Chhattisgarh, Karnataka, Kerala, Tamil Nadu, Haryana, Punjab and Rajasthan - the letter from the Home Secretary's office said.
As of 12:30 pm, Everest Kanto shares traded 17.95 per cent higher at Rs 90.70 and Linde India was locked in the 5 per cent upper circuit at Rs 1,978.25 on the BSE.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
